Table 1. Presence of HPVs in cervical cancers in the greater Middle East countries.

Country	HPVs+%	Detected HPV types	Reference
Algeria	97	16 and 18	61,62
Egypt	95	16 and 18	63–65
Iran	64–90	16, 18, 31, 33, and 45	66–72
Israel	95	16, 18, 45, 56, and 68	73–78
Jordan	85	16, 18, 31, 33, 35, 39, 45, 52, and 58	30,79
Kuwait	51	16, 18, 31, 33, 35, 39, 45, 52, and 58	80
Lebanon	43*	16, 18, and 33	30,81
Morocco	88–92	16, 18, 31, 33, and 45	(82,83)**
Pakistan	88–98	16 and 18	84,85
Saudi Arabia	82	16, 18, 31, 33, 45, 52, 56, and 56	86,87
Sudan	82–94	16, 18, 45, 52, and 58	88,89
Syria	95	16, 18, 31, 33, 35, 45, 51, 52, and 58	90
Tunisia	90	16, 18, 31, and 33	91,92
Turkey	77–100	16, 18, 31, 33, and 35	93–97

^*Abnormal tissue cases (possibly including some cancer samples). **These studies were performed on cervical cancer biopsies.